& Asa, S
NAION, A Rare but Serious Optic Nerve Risk One of the most discussed ocular concerns linked to GLP-1 therapy is non-arteritic anterior ischemic optic neuropathy, or NAION, sometimes described as an eye stroke. NAION occurs when blood flow to the optic nerve is suddenly reduced, causing painless but often permanent vision loss in one eye
Damage-associated molecular patterns in inflammatory diseases
At 20% bioavailability (achievable with optimized cyclodextrin formulations in human studies), the equivalent nasal dose drops to approximately 20mg
Because CJC-1295 acts upstream of growth hormone, its safety profile is tied to two overlapping issues: Peptide-specific effects , such as injection-site reactions or transient flushing GH/IGF-1-axis effects , such as fluid retention, joint discomfort, changes in glucose handling, or other effects associated with elevated growth hormone signaling The safety discussion is also complicated by naming
Once mixed, a typical dose is injected just under the skin (subcutaneously), usually in the abdomen